SCHEMBL43574

SCHEMBL43574

N=C(CCC(=O)OC(=O)CCC(=O)O)OC(=O)CCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 5/20 0.43
LMNA P02545 5/20 0.43
ALKBH5 Q6P6C2 1/20 0.43
SUCNR1 Q9BXA5 1/20 0.43
PHF8 Q9UPP1 6/20 0.41
KDM2A Q9Y2K7 6/20 0.41
KDM5C P41229 4/20 0.41
KDM6B O15054 2/20 0.41
ALDH1A1 P00352 1/20 0.39
KDM4E B2RXH2 3/20 0.37
FOLH1 Q04609 1/20 0.37
SLC15A2 Q16348 1/20 0.35
MAPK1 P28482 1/20 0.35
SLC13A3 Q8WWT9 1/20 0.35
OR51E2 Q9H255 1/20 0.35
TSHR P16473 2/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
KDM7A Q6ZMT4 1/20 0.32
GABRR1 P24046 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL22721956 0.94 EGLN1 (0.38) EGLN1LMNAALKBH5SUCNR1PHF8
SCHEMBL2589612 0.90 EGLN1 (0.35) EGLN1LMNAALKBH5SUCNR1PHF8
SCHEMBL34381 0.89 TSHR (0.48) EGLN1LMNAPHF8KDM2AKDM5C
SCHEMBL290459 0.89 LMNA (0.46) LMNAALDH1A1FOLH1OR51E2TSHR
SCHEMBL1230057 0.87 TSHR (0.48) LMNAALDH1A1OR51E2TSHRSLC22A6
SCHEMBL905699 0.87 TSHR (0.48) LMNAALDH1A1OR51E2TSHRSLC22A6
SCHEMBL1870547 0.87 TSHR (0.48) LMNAALDH1A1OR51E2TSHRSLC22A6
SCHEMBL905720 0.87 TSHR (0.48) LMNAALDH1A1OR51E2TSHRSLC22A6
SCHEMBL379359 0.87 TSHR (0.48) LMNAALDH1A1OR51E2TSHRSLC22A6
SCHEMBL905402 0.87 TSHR (0.48) LMNAALDH1A1OR51E2TSHRSLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5418 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4104853-B1 ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT POLARIS GROUP (KY) 2026-05-06 EP claimed
EP-4683964-A2 POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF Ocular Therapeutix, Inc. (US) 2026-01-28 EP claimed
EP-4665307-A1 BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF Ocular Therapeutix, Inc. (US) 2025-12-24 EP claimed
EP-4667566-A1 ARGININE DEIMINASE MUTANT, COVALENT DIMER AND CONJUGATE AND USE THEREOF Peg-Bio Biopharm Co., Ltd. (Chongqing) (CN) 2025-12-24 EP claimed
EP-4630058-A2 CHEMICAL TISSUE ABLATION WITH HYDROGEL MATRIX AND CORRESPONDING MEDICAL APPLICATIONS Pramand LLC (US) 2025-10-15 EP claimed
US-20250295792-A1 POLYETHYLENE GLYCOL-MODIFIED FORM OF KININ OR DERIVATIVE THEREOF AND PHARMACEUTICAL USE THEREOF ZONHON BIOPHARMA INSTITUTE, INC. (CN) 2025-09-25 US claimed
EP-4582090-A2 COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE Polaris Group (TW) 2025-07-09 EP claimed
US-20250215414-A1 COMBINATION CANCER IMMUNOTHERAPIES WITH ARGININE DEPLETION AGENTS POLARIS GROUP (KY) 2025-07-03 US claimed
EP-4568658-A1 ORGANOGELS FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF Ocular Therapeutix, Inc. (US) 2025-06-18 EP claimed
CN-119258268-B Hydrogel band-aid for bone repair and preparation method and application thereof 山东大学 2025-05-30 CN claimed
WO-1998039464-A2 ADENOVIRUS VECTORS CONTAINING HETEROLOGOUS TRANSCRIPTION REGULATORY ELEMENTS AND METHODS OF USING SAME CELL GENESYS, INC. (US) 1998-09-11 WO claimed
US-5711944-A Interferon polymer conjugates ENZON, INC. (US) 1998-01-27 US claimed
EP-0730470-A1 IMPROVED INTERFERON POLYMER CONJUGATES ENZON, INC. (US) 1996-09-11 EP claimed
CN-1126441-A Amplification of vitamin B12 absorption System Using polymers BIOTECH AUSTRALIA PTY LTD (AU) 1996-07-10 CN claimed
WO-1995013090-A1 IMPROVED INTERFERON POLYMER CONJUGATES ENZON, INC. (US) 1995-05-18 WO claimed
US-5264209-A Polyoxyethylene glycol modified interleukin derivative for hematopoietic disorders and thrombocytopenia KIRIN-AMGEN, INC. (US) 1993-11-23 US claimed
EP-0442724-A2 Modified hIL-6 Kirin-Amgen, Inc. (US) 1991-08-21 EP claimed
US-4608246-A Testing for a blood group immunological reaction IMMUCOR, INC. (US) 1986-08-26 US claimed
EP-0157797-A1 DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) IMMUCOR, INC. (US) 1985-10-16 EP claimed
WO-1985001354-A1 DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) IMMUCOR, INC. (US) 1985-03-28 WO claimed